.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Daiichi Sankyo
Argus Health
Queensland Health
Cerilliant
Accenture
QuintilesIMS
Medtronic
Teva
Dow

Generated: June 23, 2017

DrugPatentWatch Database Preview

Suppliers and packages for NDA: 021830

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Apil
ASACOL HD
mesalamine
TABLET, DELAYED RELEASE;ORAL021830NDAAllergan, Inc.0023-5901-18180 TABLET, DELAYED RELEASE in 1 BOTTLE (0023-5901-18)
Apil
ASACOL HD
mesalamine
TABLET, DELAYED RELEASE;ORAL021830NDAWarner Chilcott (US), LLC0430-0783-00273572 TABLET, DELAYED RELEASE in 1 DRUM (0430-0783-00)
Apil
ASACOL HD
mesalamine
TABLET, DELAYED RELEASE;ORAL021830NDAWarner Chilcott (US), LLC0430-0783-2712 BOTTLE in 1 CASE (0430-0783-27) > 180 TABLET, DELAYED RELEASE in 1 BOTTLE
Apil
ASACOL HD
mesalamine
TABLET, DELAYED RELEASE;ORAL021830NDAWarner Chilcott (US), LLC0430-0783-9524 CARTON in 1 CASE (0430-0783-95) > 1 BOTTLE in 1 CARTON > 12 TABLET, DELAYED RELEASE in 1 BOTTLE
Apil
ASACOL HD
mesalamine
TABLET, DELAYED RELEASE;ORAL021830NDA AUTHORIZED GENERICAmerican Health Packaging60687-264-2530 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-264-25) > 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (60687-264-95)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Cipla
Healthtrust
Federal Trade Commission
AstraZeneca
Julphar
Accenture
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot